AMN HEALTHCARE SERVICES INC (AMN) Fundamental Analysis & Valuation

NYSE:AMN • US0017441017

19.38 USD
-1.01 (-4.95%)
At close: Mar 12, 2026
19.38 USD
0 (0%)
After Hours: 3/12/2026, 7:24:19 PM

This AMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AMN. AMN was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of AMN have multiple concerns. AMN is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. AMN Profitability Analysis

1.1 Basic Checks

  • In the past year AMN was profitable.
  • In the past year AMN had a positive cash flow from operations.
  • In multiple years AMN reported negative net income over the last 5 years.
  • Each year in the past 5 years AMN had a positive operating cash flow.
AMN Yearly Net Income VS EBIT VS OCF VS FCFAMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.57%, AMN is doing worse than 67.33% of the companies in the same industry.
  • The Return On Equity of AMN (-14.90%) is worse than 62.38% of its industry peers.
  • AMN has a Return On Invested Capital (1.73%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AMN is below the industry average of 8.98%.
  • The 3 year average ROIC (6.19%) for AMN is well above the current ROIC(1.73%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -4.57%
ROE -14.9%
ROIC 1.73%
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
AMN Yearly ROA, ROE, ROICAMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • AMN's Operating Margin of 1.21% is in line compared to the rest of the industry. AMN outperforms 40.59% of its industry peers.
  • AMN's Operating Margin has declined in the last couple of years.
  • AMN has a Gross Margin (28.35%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of AMN has declined.
Industry RankSector Rank
OM 1.21%
PM (TTM) N/A
GM 28.35%
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
AMN Yearly Profit, Operating, Gross MarginsAMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

3

2. AMN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMN is destroying value.
  • AMN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for AMN has been reduced compared to 5 years ago.
  • Compared to 1 year ago, AMN has an improved debt to assets ratio.
AMN Yearly Shares OutstandingAMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AMN Yearly Total Debt VS Total AssetsAMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.47 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AMN's Altman-Z score of 2.47 is in line compared to the rest of the industry. AMN outperforms 56.44% of its industry peers.
  • The Debt to FCF ratio of AMN is 3.28, which is a good value as it means it would take AMN, 3.28 years of fcf income to pay off all of its debts.
  • AMN's Debt to FCF ratio of 3.28 is fine compared to the rest of the industry. AMN outperforms 71.29% of its industry peers.
  • AMN has a Debt/Equity ratio of 1.19. This is a high value indicating a heavy dependency on external financing.
  • AMN's Debt to Equity ratio of 1.19 is on the low side compared to the rest of the industry. AMN is outperformed by 63.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 3.28
Altman-Z 2.47
ROIC/WACC0.23
WACC7.63%
AMN Yearly LT Debt VS Equity VS FCFAMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.94 indicates that AMN may have some problems paying its short term obligations.
  • With a Current ratio value of 0.94, AMN is not doing good in the industry: 74.26% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.94 indicates that AMN may have some problems paying its short term obligations.
  • AMN has a worse Quick ratio (0.94) than 67.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
AMN Yearly Current Assets VS Current LiabilitesAMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. AMN Growth Analysis

3.1 Past

  • AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.91%.
  • AMN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.94% yearly.
  • Looking at the last year, AMN shows a decrease in Revenue. The Revenue has decreased by -8.49% in the last year.
  • The Revenue has been growing slightly by 2.67% on average over the past years.
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%

3.2 Future

  • The Earnings Per Share is expected to grow by 52.37% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 7.67% on average over the next years.
EPS Next Y36.65%
EPS Next 2Y-8.75%
EPS Next 3Y-7.38%
EPS Next 5Y52.37%
Revenue Next Year17.16%
Revenue Next 2Y-0.37%
Revenue Next 3Y1.06%
Revenue Next 5Y7.67%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMN Yearly Revenue VS EstimatesAMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
AMN Yearly EPS VS EstimatesAMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

7

4. AMN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.25, which indicates a correct valuation of AMN.
  • 80.20% of the companies in the same industry are more expensive than AMN, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of AMN to the average of the S&P500 Index (25.71), we can say AMN is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 10.43, which indicates a very decent valuation of AMN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 87.13% of the companies listed in the same industry.
  • AMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 14.25
Fwd PE 10.43
AMN Price Earnings VS Forward Price EarningsAMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMN indicates a somewhat cheap valuation: AMN is cheaper than 78.22% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 98.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.2
EV/EBITDA 8.01
AMN Per share dataAMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • AMN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A cheap valuation may be justified as AMN's earnings are expected to decrease with -7.38% in the coming years.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y-8.75%
EPS Next 3Y-7.38%

0

5. AMN Dividend Analysis

5.1 Amount

  • AMN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AMN Fundamentals: All Metrics, Ratios and Statistics

AMN HEALTHCARE SERVICES INC

NYSE:AMN (3/12/2026, 7:24:19 PM)

After market: 19.38 0 (0%)

19.38

-1.01 (-4.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners103.39%
Inst Owner Change-1.08%
Ins Owners0.38%
Ins Owner Change9.04%
Market Cap748.84M
Revenue(TTM)2.73B
Net Income(TTM)-95.70M
Analysts69.23
Price Target22.66 (16.92%)
Short Float %4.8%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)35.78%
Min EPS beat(2)-21.51%
Max EPS beat(2)93.07%
EPS beat(4)3
Avg EPS beat(4)60.31%
Min EPS beat(4)-21.51%
Max EPS beat(4)116.02%
EPS beat(8)7
Avg EPS beat(8)40.9%
EPS beat(12)11
Avg EPS beat(12)30.43%
EPS beat(16)15
Avg EPS beat(16)25.36%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.64%
Max Revenue beat(2)2.36%
Revenue beat(4)3
Avg Revenue beat(4)1.46%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)2.36%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)7
Avg Revenue beat(12)0.85%
Revenue beat(16)11
Avg Revenue beat(16)1.44%
PT rev (1m)6.51%
PT rev (3m)7.24%
EPS NQ rev (1m)1161.54%
EPS NQ rev (3m)1083.51%
EPS NY rev (1m)172.37%
EPS NY rev (3m)140.7%
Revenue NQ rev (1m)94.61%
Revenue NQ rev (3m)94.31%
Revenue NY rev (1m)24.16%
Revenue NY rev (3m)24.01%
Valuation
Industry RankSector Rank
PE 14.25
Fwd PE 10.43
P/S 0.27
P/FCF 3.2
P/OCF 2.78
P/B 1.17
P/tB N/A
EV/EBITDA 8.01
EPS(TTM)1.36
EY7.02%
EPS(NY)1.86
Fwd EY9.59%
FCF(TTM)6.05
FCFY31.23%
OCF(TTM)6.97
OCFY35.98%
SpS70.66
BVpS16.62
TBVpS-10.28
PEG (NY)0.39
PEG (5Y)N/A
Graham Number22.55
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -14.9%
ROCE 2.19%
ROIC 1.73%
ROICexc 1.77%
ROICexgc 5.91%
OM 1.21%
PM (TTM) N/A
GM 28.35%
FCFM 8.56%
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
ROICexc(3y)6.27%
ROICexc(5y)13.02%
ROICexgc(3y)21.12%
ROICexgc(5y)45.11%
ROCE(3y)7.84%
ROCE(5y)15.78%
ROICexgc growth 3Y-59.99%
ROICexgc growth 5Y-29.62%
ROICexc growth 3Y-59.19%
ROICexc growth 5Y-26.95%
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
F-Score5
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 3.28
Debt/EBITDA 4.04
Cap/Depr 22.75%
Cap/Sales 1.3%
Interest Coverage 0.74
Cash Conversion 141.99%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 2.47
F-Score5
WACC7.63%
ROIC/WACC0.23
Cap/Depr(3y)44.93%
Cap/Depr(5y)49.12%
Cap/Sales(3y)2.27%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
EPS Next Y36.65%
EPS Next 2Y-8.75%
EPS Next 3Y-7.38%
EPS Next 5Y52.37%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%
Revenue Next Year17.16%
Revenue Next 2Y-0.37%
Revenue Next 3Y1.06%
Revenue Next 5Y7.67%
EBIT growth 1Y-72.31%
EBIT growth 3Y-62.85%
EBIT growth 5Y-30.5%
EBIT Next Year231.17%
EBIT Next 3Y39.54%
EBIT Next 5YN/A
FCF growth 1Y-2.38%
FCF growth 3Y-25.82%
FCF growth 5Y1.44%
OCF growth 1Y-15.9%
OCF growth 3Y-25.58%
OCF growth 5Y0.97%

AMN HEALTHCARE SERVICES INC / AMN FAQ

What is the fundamental rating for AMN stock?

ChartMill assigns a fundamental rating of 4 / 10 to AMN.


Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?

ChartMill assigns a valuation rating of 7 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Undervalued.


How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?

AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 3 / 10.


What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?

The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to grow by 36.65% in the next year.